Literature DB >> 1594345

Babesiosis: an underdiagnosed disease of children.

P J Krause1, S R Telford, R J Pollack, R Ryan, P Brassard, L Zemel, A Spielman.   

Abstract

Babesiosis is a malaria-like illness caused by the intraerythrocytic parasite Babesia microti and is transmitted by the same tick that transmits Borrelia burgdorferi, the causative agent of Lyme disease. Babesiosis is well recognized in adult residents of southern New England and New York but has been described in only five children. To determine whether children are infected with B microti less often than are adults, a prospective serosurvey was carried out on Block Island, RI, where babesiosis is endemic. Randomly recruited subjects completed a questionnaire and provided a blood sample. Antibodies against B microti and B burgdorferi were measured using a standard indirect immunofluorescence assay and enzyme-linked immunosorbent assay, respectively. Of 574 subjects, 9% tested positive for B microti, including 12% of the 52 children (7 months through 16 years) and 8% of the 522 adults (not significant, P less than .6). Although babesiosis had not been diagnosed in any of the Babesia-seropositive subjects, 25% of the children and 20% of the adults reported symptoms compatible with this infection during the previous year. Of the 6 children and 45 adults seropositive for B burgdorferi, 17% and 14%, respectively, were also seropositive for B microti. It is concluded that children are infected with B microti no less frequently than are adults and that this infection is underdiagnosed in all age groups. Physicians who practice where Lyme disease is endemic should become familiar with the clinical presentation and diagnosis of babesiosis, both in adults and children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594345

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

Review 1.  Clinical manifestations of tick-borne infections in children.

Authors:  K A Bryant; G S Marshall
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Babesiosis.

Authors:  Edouard G Vannier; Maria A Diuk-Wasser; Choukri Ben Mamoun; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 3.  Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.

Authors:  David A Leiby
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Babesiosis in California.

Authors:  A F Jerant; A D Arline
Journal:  West J Med       Date:  1993-06

5.  Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.

Authors:  S E Marley; M L Eberhard; F J Steurer; W L Ellis; P B McGreevy; T K Ruebush
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

Review 6.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

7.  Serological expression cloning of novel immunoreactive antigens of Babesia microti.

Authors:  M J Lodes; R L Houghton; E S Bruinsma; R Mohamath; L D Reynolds; D R Benson; P J Krause; S G Reed; D H Persing
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors.

Authors:  Evan M Bloch; Andrew E Levin; Phillip C Williamson; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; Roberta Bruhn; Tzong-Hae Lee; Leilani Montalvo; Hany Kamel; Michael P Busch
Journal:  Transfusion       Date:  2016-05-17       Impact factor: 3.157

9.  Use of the Quantitative Buffy Coat system for detection of parasitemia in patients with babesiosis.

Authors:  A R Mattia; M A Waldron; L S Sierra
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany.

Authors:  Klaus-Peter Hunfeld; Annette Lambert; Helge Kampen; Sabine Albert; Christian Epe; Volker Brade; Astrid M Tenter
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.